Dual TTK/PLK1 inhibition has potent anticancer activity in TNBC as monotherapy and in combination
TTK/PLK1 双重抑制在 TNBC 中具有强效抗癌活性,无论是单药治疗还是联合治疗
期刊:Frontiers in Oncology
影响因子:3.5
doi:10.3389/fonc.2024.1447807
Elisa Zanini, Nicole Forster-Gross, Felix Bachmann, Adrian Brüngger, Paul McSheehy, Karine Litherland, Karin Burger, Anna C Groner, Mila Roceri, Luc Bury, Martin Stieger, Nicole Willemsen-Seegers, Jos de Man, Diep Vu-Pham, Helma W E van Riel, Guido J R Zaman, Rogier C Buijsman, Laurenz Kellenberger,